SCHEMBL6051450

SCHEMBL6051450

[S]CSc1cnn[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6051456 0.77 — —
SCHEMBL4311579 0.76 CYP2C9 (0.33) —
SCHEMBL14220785 0.74 — —
SCHEMBL9619930 0.72 — —
SCHEMBL4318926 0.72 MAPK1 (0.30) —
SCHEMBL9868986 0.72 — —
SCHEMBL7202635 0.72 — —
SCHEMBL11521157 0.70 KDM4E (0.30) —
SCHEMBL11521162 0.70 RAB9A (0.42) —
SCHEMBL10405093 0.69 HSD17B10 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1669351-A2 Method for preserving quaternary ammonium salt Tokuyama Corporation (JP) 2006-06-14 — — EP disclosed
EP-1178043-B1 METHOD FOR STORING QUATERNARY AMMONIUM SALT TOKUYAMA CORP (JP) 2005-12-28 — — EP disclosed
US-6852856-B2 Method for preserving quaternary ammonium salt TOKUYAMA CORPORATION (JP) 2005-02-08 — — US disclosed
EP-1423363-A1 ORAL ANTIDIABETIC AGENTS Warner-Lambert Company LLC (US) 2004-06-02 — — EP disclosed
US-20030153785-A1 Method for preserving quaternary ammonium salt TOKUYAMA CORPORATION (JP) 2003-08-14 — — US disclosed
WO-2003018553-A1 ORAL ANTIDIABETIC AGENTS WARNER-LAMBERT COMPANY LLC (US) 2003-03-06 — — WO disclosed
EP-1178043-A1 METHOD FOR STORING QUATERNARY AMMONIUM SALT TOKUYAMA CORPORATION (JP) 2002-02-06 — — EP disclosed
Send feedback